FMP
Nov 18, 2025
Home Depot (NYSE:HD), the world's largest home improvement retailer, recently reported its financial results for the third quarter of fiscal 2025. The company, known for its wide range of home improvement products, competes with other major retailers like Lowe's. Despite its strong market position, Home Depot's recent earnings report revealed some challenges.
On November 18, 2025, Home Depot announced earnings per share of $3.74, which fell short of the estimated $3.81. However, the company exceeded revenue expectations, reporting $41.35 billion compared to the estimated $41.12 billion. This revenue growth includes approximately $900 million from the acquisition of GMS Inc., contributing to an overall 2.8% increase from the same period in fiscal 2024.
Despite the revenue beat, Home Depot's stock has declined due to the earnings miss and a pessimistic outlook. The company attributes this downturn to a lack of storms and ongoing weakness in the housing market, which have negatively impacted demand. As highlighted by the Wall Street Journal, Home Depot has reported a decline in its third-quarter profit and has subsequently lowered its full-year outlook.
Net earnings for the third quarter remained steady at $3.6 billion, translating to $3.62 per diluted share, slightly down from $3.67 per diluted share in the previous year. Adjusted diluted earnings per share were $3.74, compared to $3.78 in fiscal 2024. The company's results fell short of expectations, primarily due to the absence of storms, which typically drive demand for home improvement products.
Home Depot's financial metrics provide further insight into its current position. The company has a price-to-earnings (P/E) ratio of approximately 24.36, indicating investor willingness to pay for each dollar of earnings. The price-to-sales ratio stands at about 2.14, while the enterprise value to sales ratio is around 2.25. The debt-to-equity ratio is 1.57, and the current ratio is approximately 1.05, reflecting its financial stability.
Pelthos Therapeutics Inc. (NASDAQ:PTHS) is a company operating in the biotechnology sector, focusing on developing innov...
IceCure Medical Ltd. (NASDAQ: ICCM) is a company specializing in cryoablation technology, which is a minimally-invasive ...